Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells in vitro diagnostic reagents and instruments, and vaccines in China and internationally. It operates through Diagnostics Division and Vaccine Division segments. The company offers chemiluminescence detection, biochemical, hepatitis B core antibody detection, and HIV reagents; rapid urine tests for hepa… Read more
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.010x
Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a cash flow conversion efficiency ratio of 0.010x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥127.35 Million) by net assets (CN¥12.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Betsson AB (publ)
PINK:BTSNY
|
0.026x |
|
Jereissati Participações S.A.
SA:IGTI11
|
0.029x |
|
Ryman Healthcare Limited
PINK:RHCGF
|
0.040x |
|
Acadian Asset Management Inc
NYSE:AAMI
|
-0.285x |
|
Borregaard ASA
PINK:BRRDF
|
0.071x |
|
Hakuhodo DY Holdings Inc
OTCGREY:HKUOF
|
0.072x |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
0.045x |
|
Betta Pharmaceuticals Co Ltd
SHE:300558
|
0.038x |
Annual Cash Flow Conversion Efficiency for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥12.45 Billion | CN¥355.08 Million | 0.029x | -77.09% |
| 2023-12-31 | CN¥12.88 Billion | CN¥1.60 Billion | 0.125x | -62.15% |
| 2022-12-31 | CN¥12.56 Billion | CN¥4.13 Billion | 0.329x | -10.78% |
| 2021-12-31 | CN¥4.56 Billion | CN¥1.68 Billion | 0.369x | +103.17% |
| 2020-12-31 | CN¥2.58 Billion | CN¥468.21 Million | 0.181x | +5.19% |
| 2019-12-31 | CN¥1.58 Billion | CN¥272.68 Million | 0.173x | +13.49% |
| 2018-12-31 | CN¥1.37 Billion | CN¥208.31 Million | 0.152x | -7.02% |
| 2017-12-31 | CN¥898.99 Million | CN¥146.97 Million | 0.163x | +21.25% |
| 2016-12-31 | CN¥959.70 Million | CN¥129.40 Million | 0.135x | -35.82% |
| 2015-12-31 | CN¥722.69 Million | CN¥151.84 Million | 0.210x | -7.93% |
| 2014-12-31 | CN¥580.32 Million | CN¥132.43 Million | 0.228x | -10.88% |
| 2013-12-31 | CN¥382.06 Million | CN¥97.83 Million | 0.256x | -- |